Literature DB >> 20194596

Role of host sphingosine kinase 1 in the lung response against Cryptococcosis.

Travis McQuiston1, Chiara Luberto, Maurizio Del Poeta.   

Abstract

Cryptococcus neoformans is a fungal pathogen causing pulmonary infection and a life-threatening meningoencephalitis in human hosts. The fungus infects the host through inhalation, and thus, the host response in the lung environment is crucial for containment or dissemination of C. neoformans to other organs. In the lung, alveolar macrophages (AMs) are key players in the host lung immune response, and upon phagocytosis, they can kill C. neoformans by evoking an effective immune response through a variety of signaling molecules. On the other hand, under conditions not yet fully defined, the fungus is able to survive and proliferate within macrophages. Since the host sphingosine kinase 1 (SK1) regulates many signaling functions of immune cells, particularly in macrophages, in this study we determined the role of SK1 in the host response to C. neoformans infection. Using wild-type (SK1/2(+/+)) and SK1-deficient (SK1(-/-)) mice, we found that SK1 is dispensable during infection with a facultative intracellular wild-type C. neoformans strain. However, SK1 is required to form a host lung granuloma and to prevent brain infection by a C. neoformans mutant strain lacking the cell wall-associated glycosphingolipid glucosylceramide (Delta gcs1), previously characterized as a mutant able to replicate only intracellularly. Specifically, in contrast to those from SK1/2(+/+) mice, lungs from SK1(-/-) mice have no collagen deposition upon infection with C. neoformans Delta gcs1, and AMs from these mice contain significantly more C. neoformans cells than AMs from SK1/2(+/+) mice, suggesting that under conditions in which C. neoformans is more internalized by AMs, SK1 may become important to control C. neoformans infection. Indeed, when we induced immunosuppression, a host condition in which wild-type C. neoformans cells are increasingly found intracellularly, SK1(-/-) survived significantly less than SK1/2(+/+) mice infected with a facultative intracellular wild-type strain, suggesting that SK1 has an important role in controlling C. neoformans infection under conditions in which the fungus is predominantly found intracellularly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194596      PMCID: PMC2863500          DOI: 10.1128/IAI.01140-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking.

Authors:  A Melendez; R A Floto; D J Gillooly; M M Harnett; J M Allen
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

2.  Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.

Authors:  R D Diamond; J E Bennett
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

3.  Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase.

Authors:  Yoshiko Urata; Yoshihiro Nishimura; Tetsuaki Hirase; Mitsuhiro Yokoyama
Journal:  Kobe J Med Sci       Date:  2005

4.  IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6).

Authors:  G B Huffnagle; M B Boyd; N E Street; M F Lipscomb
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

5.  Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans.

Authors:  Johanna Rivera; Arturo Casadevall
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosis.

Authors:  Christopher R Thompson; Shankar S Iyer; Natalie Melrose; Rebecca VanOosten; Korey Johnson; Stuart M Pitson; Lina M Obeid; David J Kusner
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

7.  Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells.

Authors:  Hans M Rosenfeldt; Yassine Amrani; Kenneth R Watterson; Karnam S Murthy; Reynold A Panettieri; Sarah Spiegel
Journal:  FASEB J       Date:  2003-10       Impact factor: 5.191

8.  Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.

Authors:  Maria L Allende; Teiji Sasaki; Hiromichi Kawai; Ana Olivera; Yide Mi; Gerhild van Echten-Deckert; Richard Hajdu; Mark Rosenbach; Carol Ann Keohane; Suzanne Mandala; Sarah Spiegel; Richard L Proia
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

9.  Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice.

Authors:  M Duong; N Ouellet; M Simard; Y Bergeron; M Olivier; M G Bergeron
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

10.  Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages.

Authors:  S M Levitz; S H Nong; K F Seetoo; T S Harrison; R A Speizer; E R Simons
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  20 in total

1.  Francisella tularensis LVS induction of prostaglandin biosynthesis by infected macrophages requires specific host phospholipases and lipid phosphatases.

Authors:  Aaron R Navratil; Ashley M Brummett; Joshua D Bryan; Matthew D Woolard
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

2.  The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway.

Authors:  Amir M Farnoud; Arielle M Bryan; Talar Kechichian; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

Review 3.  Sphingosine-1-phosphate receptors and innate immunity.

Authors:  Arielle M Bryan; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2018-03-23       Impact factor: 3.715

Review 4.  Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans.

Authors:  Travis J McQuiston; Peter R Williamson
Journal:  J Infect Chemother       Date:  2011-11-02       Impact factor: 2.211

5.  Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  Travis McQuiston; Chiara Luberto; Maurizio Del Poeta
Journal:  Microbiology (Reading)       Date:  2011-02-03       Impact factor: 2.777

6.  Biochemical systems analysis of signaling pathways to understand fungal pathogenicity.

Authors:  Jacqueline Garcia; Kellie J Sims; John H Schwacke; Maurizio Del Poeta
Journal:  Methods Mol Biol       Date:  2011

Review 7.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

8.  Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal.

Authors:  Ryan Rhome; Arpita Singh; Talar Kechichian; Monica Drago; Giulia Morace; Chiara Luberto; Maurizio Del Poeta
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

9.  Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans.

Authors:  Jennifer P Wang; Chrono K Lee; Ali Akalin; Robert W Finberg; Stuart M Levitz
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

10.  FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.

Authors:  Arielle M Bryan; Jeehyun Karen You; Travis McQuiston; Cristina Lazzarini; Zhijuan Qiu; Brian Sheridan; Barbara Nuesslein-Hildesheim; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.